On the heels of several big buys, Merck still has eyes for M&A—particularly in the oncology, immunology and cardiometabolic ...

Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista ...

Labcorp raised its full-year profit and revenue forecast on Thursday after posting quarterly results above expectations as ...

The acquisition is the fifth of a biotech company so far this week and, according to some Wall Street analysts, proves pharma ...

India’s pharma and healthcare deal market remains stable in Q1FY26 at 78 transactions worth USD 1.9 billion, even as overall ...

Q1 2026 earnings call: commercialization timeline, EAP traction, service lab progress, cash runway through 2027 & risks.

It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...

Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial ...

Life sciences firm Danaher topped first-quarter profit expectations on Tuesday, fueled by strong demand for its bioprocessing tools used in drug ​manufacturing, lifting shares 2% in premarket trading.

Amazon will invest as much as $25 billion in the AI company, which will secure up to 5 gigawatts in badly needed computing power in the pact. Tim Cook to Step Down as Apple Names New CEO John Ternus, ...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...